<unk>  is a anti-Infective agent ,  antimalarial that is FDA approved for the treatment of mild to moderate acute malaria caused by<unk> -susceptible strains of P. falciparum (both chloroquine-susceptible and resistant strains) or by Plasmodium vivax,  prophylaxis of P. falciparum and P. vivax malaria infections, including prophylaxis of chloroquine-resistant strains of P. falciparum.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include bradyarrhythmia, abdominal pain, diarrhea, nausea, vomiting, coordination problem, dizziness, dream disorder, headache, insomnia, somnolence, vertigo, anxiety.
Mefloquine
Artemether
Debrisoquine
Tafenoquine
Flumequine
Amodiaquine
Piperaquine
Chloroquine